1/199
Looks like no tags are added yet.
Tumor that originate from brain cells, meninges (membranes covering the brain), nerves, and glands
Primary brain tumor
Glioma
Meningioma
Oligodendroglioma
Acoustic neuroma
Pituitary adenoma
Types of primary brain tumors
Tumor from the glial cells that support and nourish nerve cells
Glioma
Tumor from the meninges (layers of the brain) that can cause increased ICP
Meningioma
Tumor from oligodendrocytes which support and insulate axons in the CNS
Oligodendroglioma
Tumor from CN VIII that can cause compression of other CNs and brain tissue
Acoustic neuroma
Tumor that causes hypersecretion of pituitary hormones
Pituitary adenoma
Acromegaly from increased GH
Amenorrhea from increased prolactin
Decreased urine output from increased ADH
Adrenal hyperfunction
S/S of pituitary adenoma
Lung
Melanoma
Renal
Breast
Colorectal
Cancers that can metastasize to the brain
Papilledema
Headache
N/V
Seizures
Decreased alertness
Cognitive impairment
Personality changes
Hemiparesis
Abnormal reflexes
Cranial nerve palsies
Ataxia
S/S of increased ICP
Swelling of the optic disk
Papilledema
One-sided muscle weakness
Hemiparesis
Lack of voluntary coordination causing clumsy movements, balance issues, and walking difficulties
Ataxia
Change in LOC
Headache
Vision changes
Seizure activity
Bradycardia
N/V
Numbness and tingling
HTN with widening pulse pressure
Pupillary changes secondary to compression of CN III
S/S of brain tumors
Comprehensive neuro exam to determine which part of the brain is affected
Biopsy to get a sample of brain tissue to stage the tumor
MRI and CT scans used to obtain a sample for the biopsy
PET and CT scans if metastasized from somewhere else
Diagnostic tests for brain tumors
Chemotherapy, radiation therapy, craniotomy
Treatment for brain tumors
Must be able to cross the blood-brain barrier to treat brain tumors
Chemotherapy
Carmustine
Temozolomide
Thiotepa
High doses of methotrexate
Chemotherapy meds
Type of chemotherapeutic agent known as a radiosensitizer given to make cancer cells more susceptible to radiation
Temozolomide
Fatigue
Diarrhea
Weight loss
N/V
Mucositis
Hair loss
Sterility
Neutropenia
Side effects of chemotherapy
Destroys both tumor and normal cells by damaging cellular DNA
Delivered by focusing on the affected area using technologies like the CyberKnife
Radiation therapy
Fatigue
Headache
Swelling
Visual changes
Neurological disturbances
Hearing loss
Facial numbness
Reddening of the skin (sunburn appearance)
Side effects of radiation therapy
A section of the skull is removed (bone flap) to biopsy brain tissue or remove the tumor
Craniotomy
Increased ICP
Intracranial hemorrhage
Vasogenic edema
Seizures
Venous thromboembolism (VTE)
Diabetes insipidus (DI)
Complications of brain tumors
Blood–brain barrier becomes inflamed and more permeable causing cerebral edema
Common after brain tumor resection
Vasogenic edema
Osmotic diuretics
Hyperventilation
HOB > 30 degrees
Dexamethasone to decrease inflammation
Treatment for vasogenic edema
Benzos during and antiepileptics after to prevent recurrence
Treatment for seizures
Bradycardia
Increased systolic BP
Irregular RR
Cushing’s triad
Occurs late in increased ICP signaling herniation syndrome, a medical emergency
Cushing’s triad
⬆ urine output, ⬇ USG, ⬇ urine osmolality, ⬆ serum sodium, ⬆ serum osmolality
S/S of diabetes insipidus
SCDs and SUBQ heparin
VTE prophylaxis
Dexamethasone to treat and prevent further cerebral edema
Osmotic diuretics to treat cerebral edema
Stool softeners to decrease Valsalva and straining which can increase ICP
Antiepileptics to prevent seizures
Heparin to prevent VTE
Opioids for pain
Meds for brain tumors
Frequent neuro checks
Vital signs
Estimated blood loss
Strict Is & Os
USG, urine osmolality, serum sodium and osmolality
Pain level
Nursing assessments for brain tumors
Administer meds as ordered
Replace urine loss and electrolytes as ordered
Elevate HOB 30-45 degrees and maintain head in good alignment
Apply SCDs
Nursing interventions for brain tumors
Taper steroid dose down, don’t stop abruptly
Glucose monitoring due to hyperglycemia from steroids
Some antiepileptics may require blood draws to ensure that they are maintained at therapeutic levels
Fall precautions due to new motor or visual deficits
Wear hats and head coverings to decrease heat loss from head due to alopecia from chemotherapy
Mouth care with soft toothbrush and non-alcoholic mouthwash to decrease mouth discomfort from sores caused by chemotherapy
Client education for brain tumors
Rapidly progressing, fatal disease of the spinal cord that causes muscle weakness and atrophy but does not impair the senses or ability to think
ALS
Other name for ALS
Lou Gehrig’s disease
Type of ALS that prominently affects the muscles involved in speech, swallowing, and tongue movements
Bulbar ALS
Other name for Bulbar ALS
Progressive bulbar palsy
Motor neurons in the brain and spinal cord progressively degenerate from oxidative stress
Motors neurons eventually die from degeneration, causing the brain to lose the ability to initiate and control muscle movement
Without direction from the CNS, muscles gradually weaken, atrophy, and twitch
Eventually all voluntary muscles are affected causing paralysis, but sensation is intact
Affects the diaphragm and chest wall, resulting in respiratory failure and the need for an artificial airway and ventilator support
Pathophysiology of ALS
Term for muscle twitching
Fasciculation
Gradual onset of progressive weakness
Hallmark sign of ALS
Muscle cramps or stiffness
Dropping objects
Uncontrolled laughter or crying
Slurred or slow speech
Difficulty swallowing (dysphagia)
Hyperreflexia (increased reflexes)
Difficulty breathing
Voice hoarseness
Head drop due to weak neck muscles
Muscle twitching
Choking or drooling due to dysphagia
Paralysis
Tongue atrophy
Other S/S of ALS
Spasticity
Sign of upper motor neuron damage
Flaccidity
Sign of lower motor neuron damage
Vitamin B12 level for deficiency
Rapid plasma reagin (RPR) for neurosyphilis
TSH level for hypothyroidism
Rheumatoid factor for rheumatoid arthritis
Creatine phosphokinase (CPK) for muscle injury
Electrolyte panel for imbalances
CBC and peripheral smear for leukemias/plasma cell dyscrasias
Anti-MAG and anti-GM1 antibodies for other neuromuscular diseases
Parathormone for deficiency
Urinalysis and 24-hour urine for heavy metals
Serum lead, acid maltase, and hexosaminidase levels for other metabolic-neuromuscular diseases
Free erythrocyte protoporphyrin for porphyrias
Diagnostic labs used to rule out conditions similar to ALS
Antinuclear antibody (ANA) as a general autoimmune screen
ESR as a general inflammatory screen
Other labs for ALS
Serum protein electrophoresis/immunofluorescent electrophoresis for protein disorders
Muscle and/or nerve biopsy
X-rays, CT scan, and MRI
Lumbar puncture to evaluate CSF protein and cytology
Electromyography (EMG) or nerve conduction velocity (NCV)
Diagnostic tests used to rule out conditions similar to ALS
Clinical manifestations of both upper and lower motor neuron damage
Genetic testing if there is a known family history
Swallow studies to see if swallowing ability has been effected
Diagnostic tests for ALS
PT, OT, and speech therapy to maximize function
Gastric feeding tube to help meet nutritional requirements
Artificial airway and mechanical ventilation when the chest and diaphragm muscles weaken
Diaphragm pacing system as an adjunct to noninvasive ventilatory support
Treatment for ALS
Muscle relaxant like baclofen for muscle cramps
Laxatives like miralax for constipation
Analeptics like modafinil for fatigue and weakness
TCAs like amitriptyline for excessive salivation, pain, and depression
Riluzole to slow disease progression and prolong the need for ventilation
Antioxidants like edaravone to reduce decline in daily functioning
Glycopyrrolate for excessive salivation
Meds for ALS
Aspiration of food or fluid
Respiratory failure
Pneumonia
Pressure injuries
DVT or PE
Constipation
Contractures
Depression
Weight loss
Loss of the ability to care for self
Complications of ALS
Airway
O2 saturation
Motor strength
Skin
Coping skills
Nursing assessments for ALS
Perform passive ROMs
Administer meds as a supportive measures
Turn, cough, and deep breath to promote gas exchange
Turn/reposition q2h to maintain skin integrity
Provide emotional support
Nursing interventions for ALS
Report increased difficulty swallowing or breathing
Inform when repositioning is needed due to discomfort
Alternative communication strategies
Client education for ALS
Acquired autoimmune disorder that affects the neuromuscular junction causing fluctuating muscle weakness and fatigue
Myasthenia gravis
Crosses the synaptic cleft and binds to ACh receptors on the postsynaptic membrane, causing skeletal muscle contraction
Normal ACh function
Anti-ACh receptor antibodies bind with ACh receptors and destroy them
Postsynaptic ACh binding is blocked and sensitivity to ACh is diminished
Skeletal muscle weakness and fatigability
Pathophysiology of myasthenia gravis
May cause the development of Anti-ACh receptor antibodies due to hyperplasia or a tumor
Thymus gland
Ocular S/S: Ptosis, diplopia
Bulbar S/S: Difficulty with speaking, chewing, and swallowing
General S/S:
Muscle weakness that increases over the course of the day
Difficulty with ADLs like bathing and dressing
S/S of myasthenia gravis
Eyelid drooping
Ptosis
Assay for anti-ACh receptor antibodies
Diagnostic lab for myasthenia gravis
Repetitive nerve stimulation
Single-fiber electromyography
Tensilon test
Chest CT scan to evaluate for thymoma
Diagnostic tests for myasthenia gravis
Measures muscle action potential after repeated nerve stimulation to evaluate neuromuscular transmission
MG result: Decreased muscle response with repetitive stimulation
Repetitive nerve stimulation
Used to detect an abnormality in neuromuscular transmission using needles placed in the muscle to measure electrical activity
MG result: Increased jitter
Single-fiber electromyography
Fluctuation of the interval between two muscle fibers firing
Jitter
Patient visually focuses on an object to test ocular muscles while up to 10 mg of edrophonium is given IV push
Positive result: Improvement of muscle weakness at 2 to 5 minutes followed by a return to baseline over the next 5 minutes
Tensilon test
Thickened liquids or enteral tube feedings
Thymectomy
Plasmapheresis
Treatment for myasthenia gravis
Surgery to treat thymoma
IV neostigmine is given to maintain muscle strength and respiratory function
Management in an intensive care unit following surgery
Thymectomy
Tumor of the thymus gland
Thymoma
Procedure that removes antibodies that block ACh receptor function from blood plasma to improve muscle strength
Plasmapheresis
Anticoagulant used to prevent clotting in the extracorporeal blood by binding with calcium to prevent calcium-dependent clotting factor reactions
Citrate
Meds like antihypertensives must be held before treatment
Instilled the catheter with heparin on nonpheresis days to prevent clotting and maintain patency
Monitor potassium and calcium levels
Medical management for plasmapheresis
A large-bore double lumen catheter is inserted
Blood is removed from the arterial lumen and circulated through the machine
Plasma is separated from the rest of the blood to remove the antibodies that block ACh receptor function
The rest of whole blood is returned through the venous lumen along with normal saline and albumin
Heparin is instilled in each lumen following treatment
Process for plasmaphersis
Citrate-induced hypocalcemia
Hypovolemia
Vasovagal reaction
Septicemia
Pneumonia
Cardiac arrhythmias
Bleeding/clotting abnormalities
Complications of plasmapheresis
Early signs: Paresthesias, vibration sensation, nausea/vomiting, and diarrhea
Late signs: Hypotension, chest tightness, tetany, and cardiac arrhythmias
S/S of hypocalcemia
Adding calcium or 5% albumin to replacement fluid
Slowing down citrate infusion
Prevention of citrate induced hypocalcemia
Pausing the procedure
Trendelenburg position if not contraindicated
Administering a bolus of normal saline
Treatment of hypovolemia and vasovagal reaction
Pallor
Diaphoresis
N/V
Hypotension
Bradycardia
S/S of vasovagal reaction
Pyridostigmine
Neostigmine
Immunosuppressants
Eculizumab
IV immunoglobulin (IVIG)
Meds for myasthenia gravis
AChE inhibitor taken PO for daily use
Initial treatment of choice for MG
Taken 30-60 mins before meals to minimize difficulty with chewing and swallowing
Missed doses can cause muscle weakness and potential respiratory difficulties
Pyridostigmine
Stomach cramps
Diarrhea
Increased secretions
Nausea
Bradycardia
Muscle twitches
Side effects of AChE inhibitors
Shorter acting AChE inhibitor given IV prior to surgery
Can cause life-threatening bradycardia or cardiac arrhythmias
IV site must be monitored frequently to ensure patency due to increased risk of infiltration
PO pyridostigmine must be given 1 hour before stopping the IV neostigmine
Neostigmine
Prednisone
Azathioprine
Cyclosporine
Mycophenolate mofetil
Cyclophosphamide
Immunosuppressants for myasthenia gravis
Complement inhibiting monoclonal antibody
Given to patients unresponsive to traditional treatments
Ensure patient has received meningococcal vaccine at least 2 weeks before the medication administration due to increased risk
Eculizumab
Donor antibody therapy that destroys anti-MuSK and anti-ACh receptor antibodies
IVIG
Myasthenic crisis
Cholinergic crisis
Complications of myasthenia gravis
Acute episode of respiratory failure often caused by a respiratory infection from viral or bacterial agents
Myasthenic crisis
Respiratory distress
Bulbar weakness
Tachycardia
Flaccid muscles
Pale and cool skin
S/S of myasthenic crisis
IVIG or plasmapheresis
Intubation and mechanical ventilation
Treatment for myasthenic crisis
Caused by excessive AChE medication
Cholinergic crisis
Fasciculations
Bradycardia
Sweating
Pallor
Excessive secretions
Small pupils
S/S of cholinergic crisis
Used to distinguish between myasthenic and cholinergic crisis because they present with similar S/S
Tensilon test
Myasthenic crisis result: Muscle strength improvement
Cholinergic crisis result: Fasciculations and muscle weakness
Results of tensilon test
Discontinuing AChE inhibitors
IV Atropine
Treatment for cholinergic crisis
Respiratory assessment
Vital capacity measurement
Muscle strength
Cranial nerve assessment
Dysphagia, dysarthria
Nutritional intake, Is & Os, daily weights
S/S of infection
Nursing assessment for myasthenia gravis
Maximum amount of air exhaled following maximal inhalation
Normal is 65 mL/kg
Mechanical ventilation is required when it falls below 15 mL/lg or 1 L
Vital capacity measurement
Administer medications at prescribed times and prior to activities requiring swallowing
Elevate HOB for eating or drinking to decrease risk for aspiration
Establish effective communication method with the patient such as a board
Plan meals when medications are at peak levels to decrease risk for aspiration
Offer soft foods and thickened liquids as recommended by the speech language pathologist
Plan for rest periods between ADLs to minimize fatigue and muscle weakness
Use equipment like a gait belt or wheeled walker when ambulating patient to prevent falls due to muscle weakness or vision changes
Nursing interventions for myasthenia gravis
Importance of taking medications as prescribed
Spare med doses should be kept in car, carry-on luggage, and at job to never a miss a dose of pyridostigmine
Wear a MedicAlert bracelet
Avoid large gatherings of people in the winter due to increased risk of infection
Obtain vaccines to prevent the flu and pneumonia to prevent myasthenic crisis
Prevent fatigue with frequent rest periods
Plan activities during peak energy periods
Don’t take OTC meds without first checking with provider or pharmacist
Client education for myasthenia gravis
Acute inflammatory demyelinating polyneuropathy that occurs after an infection and causes a rapidly progressing flaccid paralysis
GBS